GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (OTCPK:BVNRY) » Definitions » Net Margin %

Bavarian Nordic A/S (Bavarian Nordic A/S) Net Margin %

: 36.83% (As of Dec. 2023)
View and export this data going back to 2013. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Bavarian Nordic A/S's Net Income for the three months ended in Dec. 2023 was $132 Mil. Bavarian Nordic A/S's Revenue for the three months ended in Dec. 2023 was $358 Mil. Therefore, Bavarian Nordic A/S's net margin for the quarter that ended in Dec. 2023 was 36.83%.

The historical rank and industry rank for Bavarian Nordic A/S's Net Margin % or its related term are showing as below:

BVNRY' s Net Margin % Range Over the Past 10 Years
Min: -72.3   Med: 2.59   Max: 20.89
Current: 20.89


BVNRY's Net Margin % is ranked better than
89.39% of 1027 companies
in the Biotechnology industry
Industry Median: -163.32 vs BVNRY: 20.89

Bavarian Nordic A/S Net Margin % Historical Data

The historical data trend for Bavarian Nordic A/S's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Array ( [0] => - [1] => - [2] => - [3] => - [4] => - [5] => -52.34 [6] => 14.98 [7] => -24.49 [8] => -11.03 [9] => 20.89 )
Bavarian Nordic A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -52.34 14.98 -24.49 -11.03 20.89

Bavarian Nordic A/S Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.59 30.06 27.08 -24.75 36.83

Competitive Comparison

For the Biotechnology subindustry, Bavarian Nordic A/S's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bavarian Nordic A/S Net Margin % Distribution

For the Biotechnology industry and Healthcare sector, Bavarian Nordic A/S's Net Margin % distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic A/S's Net Margin % falls into.



Bavarian Nordic A/S Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Bavarian Nordic A/S's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=215.835/1033.291
=20.89 %

Bavarian Nordic A/S's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=131.882/358.059
=36.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bavarian Nordic A/S  (OTCPK:BVNRY) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Bavarian Nordic A/S Net Margin % Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic A/S's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bavarian Nordic A/S (Bavarian Nordic A/S) Business Description

Traded in Other Exchanges
Address
Philip Heymans Alle 3, Hellerup, DNK, DK-2900
Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets.

Bavarian Nordic A/S (Bavarian Nordic A/S) Headlines

From GuruFocus

Q1 2021 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2023 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2019 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Bavarian Nordic A/S Conference Call Transcript

By GuruFocus Research 02-13-2024

Bavarian Nordic A/S - Special Call Transcript

By GuruFocus Research 02-13-2024

Bavarian Nordic A/S - Special Call Transcript

By GuruFocus Research 02-13-2024

Q1 2023 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2020 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024